Morbidity and Mortality Weekly Report: MMWRU.S. Department of Health, Education, and Welfare, Public Health Service, Center for Disease Control, 1988 |
From inside the book
Results 1-5 of 63
Page 2
... laboratory test or its overuse , FIGURE 1. Lyme disease incidence , by age group - Connecticut , 1985 40 30 INCIDENCE / 100,000 POPULATION 20 O 0 0 Total cases Erythema migrans only Arthritis only 10 15 20 25 30 35 40 45 50 55 60 65 70 ...
... laboratory test or its overuse , FIGURE 1. Lyme disease incidence , by age group - Connecticut , 1985 40 30 INCIDENCE / 100,000 POPULATION 20 O 0 0 Total cases Erythema migrans only Arthritis only 10 15 20 25 30 35 40 45 50 55 60 65 70 ...
Page 1
... laboratory - based program of surveillance for Lyme disease from July 1 , 1984 , to March 1 , 1986 . Indirect immunofluorescence antibody ( IFA ) and enzyme - linked immunosorbent assays ( ELISA ) were used to detect antibodies to ...
... laboratory - based program of surveillance for Lyme disease from July 1 , 1984 , to March 1 , 1986 . Indirect immunofluorescence antibody ( IFA ) and enzyme - linked immunosorbent assays ( ELISA ) were used to detect antibodies to ...
Page 2
... laboratory test or its overuse , FIGURE 1. Lyme disease incidence , by age group 40 - Connecticut , 1985 30 20 Total cases INCIDENCE / 100,000 POPULATION 0 O 5 Erythema migrans only Arthritis only 10 15 20 25 30 35 40 45 50 55 60 65 70 ...
... laboratory test or its overuse , FIGURE 1. Lyme disease incidence , by age group 40 - Connecticut , 1985 30 20 Total cases INCIDENCE / 100,000 POPULATION 0 O 5 Erythema migrans only Arthritis only 10 15 20 25 30 35 40 45 50 55 60 65 70 ...
Page 3
... laboratories have reported sensitivities > 95 % for tests of patients with stage two or three Lyme disease ( 2,4,5 ) . Test specificities approaching 100 % have also been reported ( 2,6 ) ; however , considerable variability may occur ...
... laboratories have reported sensitivities > 95 % for tests of patients with stage two or three Lyme disease ( 2,4,5 ) . Test specificities approaching 100 % have also been reported ( 2,6 ) ; however , considerable variability may occur ...
Page 4
... laboratory test or its overuse , FIGURE 1. Lyme disease incidence , by age group - O Connecticut , 1985 40 Total cases 30 INCIDENCE / 100,000 POPULATION O 20 30 0+ T 0 5 +9 T 10 Erythema migrans only Arthritis only 15 20 25 30 35 40 45 ...
... laboratory test or its overuse , FIGURE 1. Lyme disease incidence , by age group - O Connecticut , 1985 40 Total cases 30 INCIDENCE / 100,000 POPULATION O 20 30 0+ T 0 5 +9 T 10 Erythema migrans only Arthritis only 15 20 25 30 35 40 45 ...
Common terms and phrases
AIDS amantadine antibody antigenic Ariz ATLANTIC Calif Centers for Disease chloroquine cholesterol Civilian Colo condom Congenital rubella syndrome conjugate vaccine Conn deaths Department of Health Disease Control drug E.S. CENTRAL Editor Encephalitis Epidemiology exposure Fever Gonorrhea Government Printing Office Guam Haemophilus Hawaii Health and Human health-care workers Hepatitis HIV infection Immunization infants influenza vaccine injuries Kans Legionellosis lowa Lyme disease Malaria Mass measles Minn MMWR months of age Morbidity and Mortality Mortality Weekly Report N.Y. City National Nebr notifiable diseases Ohio Okla Oreg outbreaks Pa.t patients persons Pertussis physicians Poliomyelitis polysaccharide polysaccharide vaccine Prevention Program rabies recommended Reporting Area RMSF Rubella serum specified notifiable diseases suicide survey syphilis TABLE Tenn tested Total Toxic Shock syndrome U.S. Government Printing United UNIV Upstate N.Y. Utah Viral virus W.S. CENTRAL Wash Washington weeks ending YPLL
Popular passages
Page 31 - North Carolina, North Dakota, Ohio, Oklahoma, Oregon, South Carolina, South Dakota, Tennessee, Texas, Utah, Washington, Wisconsin, and Wyoming. 5. From points in Kentucky and Ohio to points in Colorado,* Connecticut, Delaware, District of Columbia, Illinois, Indiana, Iowa...
Page 139 - Use of trade names is for identification only and does not imply endorsement by the Public Health Service or the US Department of Health and Human Services.
Page 30 - Premature mortality in the United States: public health issues in the use of years of potential life lost.
Page 279 - States and the third leading cause of years of potential life lost before the age of 65. lschemic heart disease (lHD)* accounts for 71% of all deaths due to heart disease and 27% of all mortality ( 7 ). Data from the National Center for Health Statistics' mortality public-use data tapes for 1985 were used to analyze the incidence of premature mortality due to lHD.
Page 9 - Najjar MF, Rowland M. Anthropometric reference data and prevalence of overweight, United States, 1976-80.
Page 236 - Current Population Reports, Series P-25, No. 431, August 1988, p. 1. 3. National Center for Health Statistics, "Advance Report of Final Natality Statistics, 1986," Monthly Vital Statistics Report, Vol.
Page 336 - Health; the Alcohol, Drug Abuse, and Mental Health Administration; the Health Resources and Services Administration; and the lndian Health Service.
Page 139 - Lammer EJ, Chen DT, Hoar RM, et al. Retinoic acid embryopathy. N Engl J Med 1985: 313:837-41.
Page 18 - Ou CY, Kwok S, Mitchell SW, et al. DNA amplification for direct detection of HlV-1 in DNA of peripheral blood mononuclear cells.
Page 71 - The views of the authors do not purport to reflect the position of the Department of the Army or the Department of Defense (para 4-3, AR 360-5).